AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2018
Jul 13, 2018
32566_dirs_2018-07-13_2c50882f-6f06-422b-b548-472d811eabf0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-06-30
Reporting Person: Riggsbee Richard Bryan (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-22 | Common Stock | G | 300 | $0.0 | Disposed | 109688 | Direct |
| 2018-06-25 | Common Stock | G | 500 | $0.0 | Disposed | 109188 | Direct |
| 2018-06-26 | Common Stock | G | 300 | $0.0 | Disposed | 108888 | Direct |
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2